Cargando…
Development and validation of an UPLC-MS/MS method for the quantification of ethoxzolamide in plasma and bioequivalent buffers: Applications to absorption, brain distribution, and pharmacokinetic studies
The purpose of this study is to develop and validate an UPLC-MS/MS method to quantify ethoxzolamide in plasma (EZ) and apply the method to absorption, brain distribution, as well as pharmacokinetic studies. A C(18) column was used with 0.1% of formic acid in acetonitrile and 0.1% of formic acid in w...
Autores principales: | Gao, Song, Zhao, Jing, Yin, Taijun, Ma, Yong, Xu, Beibei, Moore, Anthony N., Dash, Pramod K., Hu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507571/ https://www.ncbi.nlm.nih.gov/pubmed/25706567 http://dx.doi.org/10.1016/j.jchromb.2015.01.034 |
Ejemplares similares
-
Determination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study()
por: Chaudhary, Darshan V., et al.
Publicado: (2016) -
Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS/MS and its pharmacokinetic application
por: Tao, Yi, et al.
Publicado: (2018) -
Validated UPLC-MS/MS method for quantification of fruquintinib in rat plasma and its application to pharmacokinetic study
por: Mei, Yi-Bin, et al.
Publicado: (2019) -
Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC–MS/MS and its application in bioequivalence studies
por: Singh, Bhupinder, et al.
Publicado: (2014) -
UPLC–MS/MS assay for quantification of an inhibitor of kinases (Foretinib) in plasma: Application to a pharmacokinetic study in rats
por: Ezzeldin, Essam, et al.
Publicado: (2020)